Mohammad Hosein YAZDANPANAH, Sogol SEDİGHİ, Mohammad Reza RAJABİ, Saeed OSATİ, Azizallah DEHGHAN, Elham EHRAMPOUSH, Reza ALİPOOR, Reza HOMAYOUNFAR

Osteoporoz için Olası Katkısı Bulunan Lipid Profilleri

Amaç: Kemik yoğunluğunun azalması toplumda büyük bir sağlık sorunudur. Serum lipidleri ile kemik mineral yoğunluğu arasındaki ilişki hakkında genel bir uzlaşı yoktur. Bu çalışma, lipid profili ve osteoporoz arasındaki ilişkiyi araştırmak amacıyla yapıldı. Yöntem: Bu kesitsel çalışmada, 1500 denek Tahran'da rastgele seçildi. KMY, lunar cihazı kullanılarak DEXA ile pelvik, omurga ve toplam vücutta ölçülmüştür. SPSS v19.0'a aktarılan toplanan veriler ve lineer regresyon analitik bir test olarak gerçekleştirildi. İstatistiksel anlamlılık, 0.05'ten küçük p değerleri olarak tanımlandı. Bulgular: Bu çalışmaya toplam 1500 denek (40.88 ± 11.58 yıl) katılırken, olguların% 62'si kadın (n = 930) ve % 38'i erkektir (n = 570). Yaş, cinsiyet ve menopoz durumu pelvik KMY ile ilişkiliydi (p değeri

Lipid Profiles as a Possible Contributor to Osteoporosis

Objectives: Reducing bone density is a major health problem in society. Thereis no general agreement on the relationship between serum lipids and bonemineral density. This study was conducted to investigate the associationbetween lipid profile and osteoporosis.Material and Methods: In this cross-sectional study, 1500 subjects wererandomly selected from Tehran. BMD was measured in pelvic, spine and totalbody by DEXA using the lunar device. Collected data imported to SPSS v19.0and linear regression was performed as an analytic test. Statistical significantwas defined as P-values less than 0.05.Results: Totally 1500 subjects participate in this study (age 40.88±11.58yr),62% of subjects were female (n=930) and 38% were male (n=570). Age, sexand menopausal status were related to pelvic BMD (p-value

PDF

___

Jamshidian-Tehrani M, Kalantari N, Azadbakht L, Esmaillzadeh A, Rajaie A, Houshiar-Rad A, et al. Osteoporosis risk factors in Tehrani women aged 40-60 years. Iranian Journal of Endocrinology and Metabolism. 2004;6:139-45.
Soltani AAF, Pazhouhi M, Bastan HM, Mirfeizi SZ, Dashti R, Hosseinnezhad A. Bone mineral density variations in 20-69 yr. population of Tehran/Iran. 2002.
Zamani B, Ebadi SA, Ahmadvand A, Moosavi GA. The Frequency of Osteoporosis in Hip Fracture Following Minor Trauma and The Resulting Mortality Rate and Direct Treatment Costs In Patients Over 45 Years Old In Kashan Naghavi Hospital During 2005-2007. Journal of Kerman University of Medical Sciences. 2010;17:137-44.
Melton LJ. The prevalence of osteoporosis. Journal of Bone and Mineral Research. 1997;12:1769-71.
Taghizadeh.Z ZM, Mortaz Hejri.S, Maghboli.G, Kazemnezhad.A, Pazhohi.M,. investigating the air pollution with bone density measurements and bone biochemistry indicators in various residents of Tehran. University of Medical Sciences, Journal of Reproduction and infertility. 2004;1:43-52.
Amiri M LB, Nabipour I, Moosavi SF, Amiri Z, Soltanian A, et al. The prevalence of osteoporosis in 20-69 years old women in Bushehr port. 2004;7:61-9.
Urano T, Inoue S. Recent genetic discoveries in osteoporosis, sarcopenia and obesity. Endocrine journal. 2015;62:475-84.
Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clinical interventions in aging. 2015;10:583.
Jeynes KD, Gibson EL. The importance of nutrition in aiding recovery from substance use disorders: A review. Drug and alcohol dependence. 2017;179:229-39.
Rizzoli R, Bischoff-Ferrari H, Dawson-Hughes B, Weaver C. Nutrition and bone health in women after the menopause. Women’s Health. 2014;10:599- 608.
Ehrampoush E, Homayounfar R, Davoodi SH, Zand H, Askari A, Kouhpayeh SA. Ability of dairy fat in inducing metabolic syndrome in rats. SpringerPlus. 2016;5:2020.
Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clinical medicine. 2014;14:187-91.
Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. The Journal of steroid biochemistry and molecular biology. 2014;142:155-70.
Patsch JM, Deutschmann J, Pietschmann P. Gender aspects of osteoporosis and bone strength. Wiener medizinische Wochenschrift. 2011;161:117-23.
Krejci CB, Bissada NF. Women's health: periodontitis and its relation to hormonal changes, adverse pregnancy outcomes and osteoporosis. Oral health & preventive dentistry. 2012;10(1).
Segev D, Hellerstein D, Dunsky A. Physical activity-does it really increase bone density in postmenopausal women? A Review of articles published between 2001-2016. Current aging science. 2017.
Park C-H, Lee Y-K, Koo K-H. Knowledge on osteoporosis among nurses. Journal of bone metabolism. 2017;24:111-5.
Beaudart C, Dawson A, Shaw S, Harvey N, Kanis J, Binkley N, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporosis International. 2017;28:1817-33.
Compston JE, McConachie C, Stott C, Hannon RA, Kaptoge S, Debiram I, et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2006;17:77-84.
Del Valle HB, Yaktine AL, Taylor CL, Ross AC. Dietary reference intakes for calcium and vitamin D: National Academies Press; 2011.
Osati S, Homayounfar R, Hajifaraji M. Metabolic effects of vitamin D supplementation in vitamin D deficient patients (a double-blind clinical trial). Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016;10:S7- S10.
Wallach JB. Interpretation of diagnostic tests: Lippincott Williams & Wilkins; 2007.
Saghafi H, Hossein-Nezhad A, Rahmani M, Larijani B. Relationship between lipid profile and bone turnover in pre and postmenopausal women. Iranian J Publ Health Suppl. 2008:23-9.
Semler JC. Risk factors for osteoporosis in men. Bone and Mineral. 1992;17:178.
Brownbill RA, Ilich JZ. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. Journal of Women's Health. 2006;15:261-70.
Samelson EJ, Cupples LA, Hannan MT, Wilson PWF, Broe KE, Zhang YQ, et al., editors. Long-term effects of serum cholesterol over 34 years on bone mineral density (BMD) in women and men: the framingham osteoporosis study. Journal of bone and mineral research; 2002: Amer Soc Bone & Mineral Res 2025 M St, Nw, Ste 800, Washington, DC 20036-3309 USA.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972;18:499-502.
Samelson EJ, Cupples LA, Hannan MT, Wilson PWF, Williams SA, Vaccarino V, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone. 2004;34:557- 61.
Pérez-Castrillón J-L, De Luis D, Martın-Escudero JC, Asensio T, del Amo R, ́ Izaola O. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. Journal of diabetes and its complications. 2004;18:317-21.
Tanko LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone. 2003;32:8-14.
Sahmani M, Omidian S, Javadi A, Sabet MS, Abbasi M. Association between the serum levels of zinc, copper and lipid profile with osteoporosis in Iranian postmenopausal women. Biotechnology and Health Sciences. 2014;1:8,12.
Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocrine journal. 2002;49:211-7.
Orozco P. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. European journal of epidemiology. 2004;19:1105-12.
Cui L-H, Shin M-H, Chung E-K, Lee Y-H, Kweon S-S, Park K-S, et al. Association between bone mineral densities and serum lipid profiles of preand post-menopausal rural women in South Korea. Osteoporosis International. 2005;16:1975-81.
Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcified tissue international. 2004;74:136-42.
Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. Osteopontin Expression in Cardiovascular Diseasesa. Annals of the New York Academy of Sciences. 1995;760:109-26.
Tanko LB, Bagger YZ, Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcified tissue international. 2003;73:15-20.
Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins, leukotrienes and essential fatty acids. 2003;68:373-8.
D’Amelio P, Pescarmona GP, Gariboldi A, Isaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause. 2001;8:429-32.
Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arteriosclerosis, thrombosis, and vascular biology. 2000;20:2346-8.
Arjmandi BH, Juma S, Beharka A, Bapna MS, Akhter M, Meydani SN. Vitamin E improves bone quality in the aged but not in young adult male mice. The Journal of nutritional biochemistry. 2002;13:543-9.
Parhami F, Demer LL. Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids? Current opinion in lipidology. 1997;8:312-4.
Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. Journal of Biological Chemistry. 1997;272:13597-607.
Frye MA, Melton LJ, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, et al. Osteoporosis and calcification of the aorta. Bone and mineral. 1992;19:185-94.
Boukhris R, Becker KL. Calcification of the aorta and osteoporosis: a roentgenographic study. Jama. 1972;219:1307-11.
Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL. 8- Isoprostaglandin E2 enhances receptor-activated NFκB ligand (RANKL)- dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. Journal of Biological Chemistry. 2002;277:14221-6.
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis 1. Endocrine reviews. 2000;21:115-37.
Van Lenten BJ, Wagner AC, Navab M, Fogelman AM. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. Journal of Biological Chemistry. 2001;276:1923-9.
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms. Circulation. 1995;91:2488-96.